Oxytocin improves social abilities in some kids with autism, study finds

July 10, 2017
Spacefilling model of oxytocin. Created using ACD/ChemSketch 8.0, ACD/3D Viewer and The GIMP. Credit: Wikipedia.

Children with autism showed improved social behavior when treated with oxytocin, a hormone linked to social abilities, according to a new study by researchers at the Stanford University School of Medicine. Children with low oxytocin benefited most from the medication, the study found.

The study, which will be published online July 10 in the Proceedings of the National Academy of Sciences, is the first to consider how baseline levels influence autistic children's responses to the substance.

"Our results suggest that some children with will benefit from oxytocin treatment more than others, and that blood oxytocin levels might be a biological sign that will allow us to predict if a child will respond maximally or not," said lead author Karen Parker, PhD, associate professor of psychiatry and behavioral sciences. The trial, in 32 children, was relatively small and needs to be replicated, she said.

"We are finally narrowing down whom oxytocin could be beneficial for," said Antonio Hardan, MD, professor of psychiatry and behavioral sciences and senior author of the study. "This is what precision health looks like for autism."

Although the effect of oxytocin was modest, the results are exciting because no other medications now exist to treat any of the core features of autism, Hardan added.

Oxytocin levels vary

Autism is a developmental disorder characterized by poor social ability and verbal communication skills, as well as restrictive and . Not all children with the disorder are equally affected; symptoms range in severity. In 2014, Parker and Hardan and their colleagues discovered that oxytocin levels vary greatly in children both with and without autism, and that those with low oxytocin have more social impairment regardless of whether they have autism.

That discovery made the researchers wonder if oxytocin's benefits as an autism therapy might be confined to kids whose levels were low to begin with. Other trials of oxytocin in autism have produced mixed results but did not take subjects' baseline levels into account.

The new study included 32 children with autism who were randomly assigned to receive an intranasal oxytocin spray or a placebo spray twice daily for four weeks. The children's blood oxytocin levels were measured before and after the four-week period. The children's behavior was assessed at the beginning and end of the trial using a standardized questionnaire completed by their parents. The hormone was found to be safe, with no adverse events reported.

Intriguing placebo effect

As in many trials, the researchers saw some improvement even in children given the placebo, though the effect was less pronounced than it was in the oxytocin group. Children who had low oxytocin at baseline received more benefit from placebo than those who began with high oxytocin—and their bodies' own production of the hormone rose modestly. This unexpected finding suggests a possible biological explanation for the placebo effect, which is common in studies of psychological and psychiatric treatments, Parker said. The idea that increases in natural oxytocin production might explain how patients benefit from a placebo merits future research, she added.

Among the children who got oxytocin, those with the lowest oxytocin levels at the beginning of the trial experienced the greatest improvements in social behavior. Oxytocin's effects were specific: the hormone did not change the frequency of repetitive behaviors, nor did it affect children's anxiety levels.

A large trial of oxytocin for children with autism is now underway at several institutions across the United States, and Hardan and Parker are curious about whether the bigger trial will replicate their findings. Hardan, who treats with autism at Lucile Packard Children's Hospital Stanford, is not advocating that physicians start prescribing oxytocin for their patients yet.

"If our findings are replicated in the large NIH-funded trial, then I might consider doing baseline oxytocin measurements as part of my clinical practice to try to determine if specific patients will respond," he said, noting that this could be difficult because, at present, blood are not measured routinely in clinical labs. Oral or sublingual administration of oxytocin would not necessarily produce the same results as the intranasal oxytocin tested, he also cautioned.

"Hopefully, this is a first step to identifying the characteristics of people with autism who respond to specific treatments," Hardan said. "Because of the heterogeneity of the disorder, we need to start doing clinical not to see if there will be a response, but more to see who will respond to possible treatments."

The work is an example of Stanford Medicine's focus on precision health, the goal of which is to anticipate and prevent disease in the healthy and precisely diagnose and treat disease in the ill.

Explore further: Nasally administered oxytocin increases emotion perception in autism

More information: Karen J. Parker el al., "Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism," PNAS (2017). www.pnas.org/cgi/doi/10.1073/pnas.1705521114

Related Stories

Nasally administered oxytocin increases emotion perception in autism

May 25, 2017
A recent study has demonstrated that intranasal oxytocin can influence how individuals with autism perceive emotion in others. This is an important first step for a potential pharmacological treatment of autism.

Blood-oxytocin levels in normal range in children with autism

August 4, 2014
Autism does not appear to be solely caused by a deficiency of oxytocin, but the hormone's universal ability to boost social function may prove useful in treating a subset of children with the developmental disorder, according ...

A single spray of oxytocin improves brain function in children with autism

December 2, 2013
A single dose of the hormone oxytocin, delivered via nasal spray, has been shown to enhance brain activity while processing social information in children with autism spectrum disorders, Yale School of Medicine researchers ...

Combination approach may boost social interactions in autism

May 2, 2017
The hormone oxytocin, the so-called hug hormone or cuddle chemical, has more nicknames than proven medical uses. However, oxytocin may benefit children with autism spectrum disorders if receptors for opioids—brain chemicals ...

Induction with concurrent oxytocin, foley speeds delivery

May 25, 2017
(HealthDay)—The rate of delivery within 24 hours is increased with induction with concurrent oxytocin infusion added to preinduction cervical ripening with a Foley catheter versus Foley followed by oxytocin, according to ...

Low levels of hormone linked to social deficit in autism, study finds

July 22, 2015
A brain-chemistry deficit in children with autism may help to explain their social difficulties, according to new findings from the Stanford University School of Medicine.

Recommended for you

Late-breaking mutations may play an important role in autism

July 17, 2017
A study of nearly 6,000 families, combining three genetic sequencing technologies, finds that mutations that occur after conception play an important role in autism. A team led by investigators at Boston Children's Hospital ...

Females with autism show greater difficulty with day-to-day tasks than male counterparts

July 14, 2017
Women and girls with autism may face greater challenges with real world planning, organization and other daily living skills, according to a study published in the journal Autism Research.

Researchers investigate possible link between carnitine deficiency and autism

July 13, 2017
Researchers are always looking for new clues to the causes of autism, with special emphasis on prevention or treatment. At Baylor College of Medicine, Dr. Arthur Beaudet has been following clinical and genetic clues in patients ...

How children look at mom's face is influenced by genetic factors and altered in autism

July 12, 2017
New research has uncovered compelling evidence that genetics plays a major role in how children look at the world and whether they have a preference for gazing at people's eyes and faces or at objects.

Oxytocin improves social abilities in some kids with autism, study finds

July 10, 2017
Children with autism showed improved social behavior when treated with oxytocin, a hormone linked to social abilities, according to a new study by researchers at the Stanford University School of Medicine. Children with low ...

Possible early diagnosis of autism spectrum disorder

June 29, 2017
Measuring a set of proteins in the blood may enable earlier diagnosis of autism spectrum disorder (ASD), according to a study from the Peter O'Donnell Jr. Brain Institute at UT Southwestern Medical Center.

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

BubbaNicholson
1 / 5 (1) Jul 11, 2017
Since pheromones can effect Oxytocin release, human pheromone should help alleviate symptoms of ASD, right? Right. 250mg of healthy adult male facial skin surface lipid pheromone taken by mouth on fresh, new, un-chewed chewing gum vehicle diminish symptoms of ASD.
Captain Stumpy
not rated yet Jul 11, 2017
@fanatical religious quack bubbanich, the lying POS
right?
WRONG

otherwise you would be able to produce empirical evidence supporting your claims
and in science circles, that means not only providing peer reviewed studies from reputable journals, it also means supplying "robust bioassay-led evidence for the widely published claims that four steroid molecules are human pheromones" ( http://rspb.royal...full.pdf )... which you have no evidence for

specifically, that makes your claims completely and totally religious fanaticism
not science

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.